AOD-9604 vs MOTS-c: Metabolic Peptide Comparison
A concise comparison of AOD-9604 and MOTS-c — two metabolic research peptides with different origins, mechanisms, and research applications.
In-depth research guides covering peptides, compounds, and laboratory supplies. For research use only.
A concise comparison of AOD-9604 and MOTS-c — two metabolic research peptides with different origins, mechanisms, and research applications.
NorthPeptide backs every order with three guarantees: 99% HPLC-verified purity, free customs reship, and arrival protection. Learn how each guarantee works and how to make a claim.
A day-by-day account of starting peptides — based on clinical data and public reports.
GLP-1 peptides reduce appetite — but nutrition still matters. Here’s what to eat and why.
A concise comparison of Semax and Selank — two Russian-developed neuropeptides with distinct mechanisms, cognitive effects, and research applications.
The Evolution From Single to Triple Receptor Targeting The development of GLP-1 receptor agonists represents one of the most significant advances in metabolic research over the past decade. What began with single-receptor compounds like semaglutide has rapidly evolved into dual and triple agonists that target multiple metabolic pathways simultaneously — each generation producing larger effect…
Considering switching from tirzepatide to retatrutide? Compare the dual vs triple agonist mechanisms, clinical trial data, dosing protocols, and what researchers are reporting.
Most people notice appetite changes within 1-2 weeks on retatrutide. Here’s the full timeline.
Can you drink alcohol on peptides? What the research says about GLP-1s, BPC-157, and NAD+.
A concise comparison of Sermorelin and CJC-1295 — two GHRH-based peptides with different half-lives, mechanisms, and research applications.